COVID-19 is making a comeback in several countries
Recently, the positive rate of COVID-19 has been increasing globally, with increases in the Eastern Mediterranean, Europe and the Americas, and decreases in other regions. At present, JN.1, KP.2 and KP.3 are the main circulating strains in the world, and the variant strain LB.1 is listed as a variant strain under surveillance (VUM) by WHO.
CDC data show that the proportion of KP.3 strains detected continued to rise, from 31.3% to 36.9% during the nearly two-week surveillance period. The LB.1 strain increased slightly, from 13.0% to 14.9%. The KP.3 and LB.1 strains are descendants of the Omicron strain, both of which are part of the JN.1 branch, and whose mutations allow them to better evade immunity from early infection or vaccination, but they are still highly infectious and less pathogenic.
The latest report from the European Centre for Disease Control and Prevention (ECDC) says that after a long period of low epidemic levels, the positive rate of the novel coronavirus is once again on the rise in many countries. Surveillance data shows that as of June 9, the positive rate of COVID-19 in primary sentinel hospitals in EU countries increased to 18.3% in seven weeks. Among them, people aged 65 years and older had the largest increase in positive rates. FLiRT variant has been widely prevalent in the UK, Spain, France and other countries, while a number of summer sports events are hot, the number of new coronavirus infections in many countries in Europe has increased in recent months.
In June, the scientific journal Scientific American published a special report written by LAUREN J. Young, associate editor of health and medicine, "New FLiRT variant may lead to an increase in cases during the year, and there are ways to avoid infection," saying that U.S. public health experts are concerned that there may be a spike in cases during the summer. Experts advise people who are eligible for additional doses or who have not yet been vaccinated to get their current vaccine immediately, wear a face mask during summer travel and vacation, and carry a rapid test for COVID-19.
Wizbiotech's Colloidal Gold test for COVID-19 antigen can be performed in 10-15 minutes and is easy to use without relying on an instrument! The reagent was approved for export in 2020, and in many countries such as Germany, Italy, Spain, Finland, and the Netherlands, we worked together to overcome the epidemic difficulties. In the face of the resurgence of the epidemic, we will continue to work hard to ensure production and quality control.
Welcome the hospital purchasing department and related institutions to consult and place orders, we will provide the best quality medical services for your hospital to provide better support and help. We look forward to working with you to safeguard public health.
